Jamie Freedman, M.D., Ph.D. Joins OPKO Health as Executive Vice President of R&D and Business Development Jun 12, 2009
OPKO To Present Data on Next Generation Anti-Angiogenic VEGF165b-Sparing siRNA at Association for Research and Vision in Ophthalmology (ARVO 2009) Meeting Feb 10, 2009
OPKO Health Announces Completion of Enrollment for Its Phase III Clinical Trial of Bevasiranib for Treatment of AMD Dec 4, 2008
OPKO Acquires Worldwide Ophthalmic Rights to Teva's Budesonide for Inflammatory and Allergic Ocular Conditions Oct 2, 2008
